Bristol/Sanofi's Plavix Settlement Faces Justice Department Criminal Investigation
This article was originally published in The Pink Sheet Daily
Executive Summary
Bristol's conduct relating to the settlement with Apotex was "appropriate," CEO Dolan maintains.